Login

Stéphane Poupinel de Valencé - CEO, New Mauritius Hotels Ltd.| 00:10:00

Share On Facebook Share On Twitter

Discussion about New Mauritius Hotels Ltd. growth and improvement

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Power of Being a Generalist: Insights from David Epstein | Podcast Episode on In Good Company by Norges Bank Investment Management
00:10:00
TTG Weekly Update: July 12, 2024 - Inflation Trends and Portfolio Adjustments | Jim Kotagides, President , TTG Financial Inc.
00:10:00
E3 Metals Corp: Pioneering Lithium Extraction from Alberta's Leduc Reservoir
00:10:00
Matt Riehle: Championing Diversity at Morgan Lewis | MATTHEW N. RIEHLE - ASSOCIATE of Morgan, Lewis & Bockius LLP
00:10:00
New Mosca Lithium: Pioneering Vertical Integration in Quebec's Lithium Market
00:10:00
Panorama Minerals: Advancing Copper Exploration Projects in Peru
00:00:00
Redx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz Pharma - Lisa Anson Chief Executive Officer, Redx Pharma
00:10:00
AAK AB Q1 2024 Interim Report: CEO Johan Westman’s Insights | Johan Westman, CEO , AAK AB.
00:10:00
Transforming Loan Markets: Arnaud Teissier on iLex's Innovation in Maritime Finance | Arnaud Teissier - Co-founder & Head of Sales, iLex
00:00:00
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)
00:10:00
CEO David Solomon Highlights Asset and Wealth Management as Key Strategic Opportunity in Discussion on 'Squawk Box' During the Company's Second-Ever Investor Day
00:10:00
Sean Trauschke, newly appointed CEO of OGE Energy Corp., discusses his past positions and future plans in an interview.

© 2026 Nehu